DeepMed Research

Alliance for Clinical Trials in Oncology

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 2011-01-01

Employees: 251

Market Cap: -

Website: https://www.allianceforclinicaltrialsinoncology.org

Clinical Trials

Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas

Phase 2

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: cisplatin
Drug: docetaxel
Drug: gemcitabine hydrochloride
Drug: irinotecan hydrochloride

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-14

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 259

Registration Number: NCT00012220

Locations: 🇺🇸
Veterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, United States
🇺🇸
CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States
🇺🇸
Veterans Affairs Medical Center - Asheville, Asheville, North Carolina, United States

and more 73 locations

Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia

Phase 2

Completed

Conditions: Precancerous Condition
Cervical Cancer

Interventions: Drug: imiquimod
Procedure: Ablative or excisional therapy

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 57

Registration Number: NCT00031759

Locations: 🇺🇸
CCOP - Sioux Community Cancer Consortium, Sioux Falls, South Dakota, United States
🇺🇸
Mayo Clinic, Jacksonville, Florida, United States
🇺🇸
CCOP - Carle Cancer Center, Urbana, Illinois, United States

and more 5 locations

Positron Emission Tomography for Detecting Non-small Cell Lung Cancer

Not Applicable

Completed

Conditions: Lung Cancer

Interventions: Procedure: positron emission tomography
Procedure: radionuclide imaging
Radiation: fludeoxyglucose F 18

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 303

Registration Number: NCT00004138

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸
University of Chicago Cancer Research Center, Chicago, Illinois, United States
🇺🇸
Lutheran General Hospital, Park Ridge, Illinois, United States

and more 20 locations

Genetic Markers in Patients With Colorectal Cancer

Completed

Conditions: Colorectal Cancer

Interventions: Genetic: DNA stability analysis
Genetic: loss of heterozygosity analysis
Genetic: microsatellite instability analysis

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 675

Registration Number: NCT00014079

Locations: 🇺🇸
Mayo Clinic Cancer Center, Rochester, Minnesota, United States
🇺🇸
CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic - Jacksonville, Jacksonville, Florida, United States

Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer

Phase 3

Completed

Conditions: Breast Cancer

Interventions: Other: immunohistochemistry staining method
Procedure: lymphangiography
Procedure: sentinel lymph node biopsy
Procedure: therapeutic conventional surgery
Radiation: whole breast irradiation

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 4590

Registration Number: NCT00003854

Locations: 🇺🇸
York Cancer Center, York, Pennsylvania, United States
🇺🇸
Zale Lipshy University Hospital, Dallas, Texas, United States
🇺🇸
University of Washington Medical Center, Seattle, Washington, United States

and more 113 locations

Irinotecan in Treating Aging Patients With Solid Tumors

Phase 1

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Drug: irinotecan hydrochloride

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-06

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 140

Registration Number: NCT00026195

Locations: 🇺🇸
CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States
🇺🇸
North Shore University Hospital, Manhasset, New York, United States
🇺🇸
Vermont Cancer Center, Burlington, Vermont, United States

and more 44 locations

Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy

Phase 3

Completed

Conditions: Pain
Neurotoxicity

Interventions: Other: placebo
Drug: gabapentin

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-04

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 100

Registration Number: NCT00027963

Locations: 🇺🇸
CentraCare Health Plaza, Saint Cloud, Minnesota, United States
🇨🇦
Allan Blair Cancer Centre, Regina, Saskatchewan, Canada
🇺🇸
Mayo Clinic, Jacksonville, Florida, United States

and more 20 locations

Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer

Not Applicable

Completed

Conditions: Head and Neck Cancer

Interventions: Other: immunohistochemistry staining method
Procedure: conventional surgery
Procedure: lymphangiography
Procedure: radionuclide imaging
Procedure: sentinel lymph node biopsy
Radiation: technetium Tc 99m sulfur colloid

First Posted Date: 2003-01-27

Last Posted Date: 2016-12-07

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 161

Registration Number: NCT00042926

Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia

Active, not recruiting

Conditions: Leukemia
Acute Lymphoblastic Leukemia
Acute Promyelocytic Leukemia

Interventions: Other: laboratory biomarker analysis

First Posted Date: 2003-01-27

Last Posted Date: 2023-08-31

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 840

Registration Number: NCT00003861

Locations: 🇺🇸
Maine Center for Cancer Medicine and Blood Disorders - Scarborough, Scarborough, Maine, United States
🇺🇸
Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States
🇺🇸
Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, United States

and more 48 locations

Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma

Phase 2

Completed

Conditions: Lymphoma

Interventions: Biological: filgrastim
Biological: rituximab
Drug: carmustine
Drug: cyclophosphamide
Drug: cytarabine
Drug: doxorubicin hydrochloride
Drug: etoposide
Drug: leucovorin calcium
Drug: methotrexate
Drug: prednisone
Drug: vincristine sulfate
Procedure: peripheral blood stem cell transplantation

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-19

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 79

Registration Number: NCT00020943

Locations: 🇺🇸
Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States
🇺🇸
Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸
Ellis Fischel Cancer Center at University of Missouri - Columbia, Columbia, Missouri, United States

and more 78 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy